Added 6 days ago Drug news

New Xerava data presented at Annual Surgical Infection Society Meeting for treatment of complicated intra-abdominal infections.

Tetraphase Pharmaceuticals, Inc announced the presentation of positive data from three studies further evaluating its lead compound, Xerava (eravacycline), a...

Added 9 days ago Drug news

New trial required by FDA for iclaprim, for the treatment of acute bacterial skin and skin structure infections

Motif Bio plc announced that the Company has received the official minutes of the Type A meeting the Company held...

Added 1 month ago Drug news

BC 3781 file with EU for community-acquired pneumonia

Nabriva Therapeutics announced that the Company’s marketing authorization application (MAA) for both the intravenous (IV) and oral formulations of BC...

Guidelines on Urological Infections

The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...

Added 3 years ago

The Prevention of Early-onset Neonatal Group B Streptococcal Disease

The purpose of this guideline is to provide guidance for obstetricians, midwives and neonatologists on the prevention of early-onset (less than 7 days of age) neonatal group B streptococcal (EOGBS) disease...

Added 6 years ago

Fever in under 5s: assessment and initial management

This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5.

Added 6 years ago

Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.

The CFTR potentiator, ivacaftor (IVA), has been widely used in the treatment of cystic fibrosis (CF) patients with the G551D mutation. To date, there has been limited information on the microbiological status...

Added 1 year ago

Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit.

Added 2 years ago

Early, goal-directed therapy for septic shock – a patient-level meta-analysis.

After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septicshock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit.

Added 2 years ago